logo
How To Succeesfully Navigate The Three Stages Of Your Career

How To Succeesfully Navigate The Three Stages Of Your Career

Forbes06-05-2025
Portrait of three happy coworkers smiling looking at camera in the office. Business concept. getty
After graduating college, there is a mixture of exhilaration, and fear. This is not one of the best job markets for young adults. A 2024 report by the Burning Glass Institute and Strada Institute for the Future of Work, titled ' Talent Disrupted ,' found that 52% of recent four-year college graduates are underemployed one year after graduation. This means that they are working in jobs that don't require a bachelor's degree.
Don't let this bother you. For many recent college graduates, they'll knock around for a while. Others who are lucky, will be on the fast track. Over the span of years, situations change. The initial hard chargers may burn out. If you keep trying, you'll find your way.
A career will span many decades. Therefore, think in terms of visualizing your career developing over the years. It's more of a marathon than a sprint. Consider breaking down your overall career arc into three distinct parts . Each phase presents unique opportunities and challenges. It runs the gamut from launching a career after college to figuring out what to do after you're ready to retire.
Early-career workers need to cultivate an array of relevant skills in their field. Mid-career professionals aggressively build their careers. Late-career workers can reinvent themselves through advisory or passion-driven roles. Ultimately, you'll need a financial plan for exiting the workforce, with a cushion of funds to allow you to enjoy your golden years.
It may not be easy for some people. We're in a fast moving job market, economy, and workplace. The rapid acceleration of AI, automation, robotics and other technologies can change the game overnight. These tools have both the power to help your career thrive, or you may lose your position due to AI.
Workers can't be complacent. Even if you have a good job and a nice compensation package, it doesn't mean it will last. The key is to continually move forward and be able to quickly adapt to changes. This includes getting training, finding a mentor, and learning new things to stay relevant and ahead of the curve. Upskilling is vital. A 2024 LinkedIn Workplace Learning Report found 74% of workers prioritize growth opportunities, and platforms like Udemy offer courses in AI or project management The Early Stages
Your early career stage starts after college. Some people graduate in a field such as software engineering with lots of opportunities and large compensation packages. Others may find themselves a little lost. They can't seem to find the right opportunity. Recent graduates face a competitive landscape, with Handshake's 2024 survey of 1,925 Class of 2025 students revealing that 57% feel pessimistic about job prospects due to market tightness and AI's impact. Don't despair. This has happened every generation. Getting the first job is mission critical. It gets your foot in the door.
Try to learn as much as possible. Find mentors, coaches and sponsors who can offer advice and guidance. Volunteer for almost everything. You want to be the go-to person in the office. You'll cultivate a reputation for being a team player and delivering on your promises. Also, it shows that you can get along with coworkers, managers and clients, which isn't easy to do.
Young professionals, particularly Gen Z, face a tight job market and AI-driven disruptions. To thrive, you'll need to focus on acquiring versatile skills, such as digital literacy and problem-solving, which a 2024 World Economic Forum report identifies as critical for 60% of jobs by 2030. Seek out roles in growing sectors like technology, healthcare, finance or sustainability, even if they require starting at entry-level positions. Your Mid-Career
The mid-career stage , often spanning the 15 to 25 year mark, is a period of peak productivity. You've cultivated confidence and the respect of your peers and managers. If you're so inclined, mid-career workers should start working on ways to obtain senior leadership opportunities.
As you are climbing the corporate ladder, it's the time when you start making progress and earning some real money. You'll want to start setting aside funds for the future. Look into opening a brokerage account, if you don't have one already. Find out about CD rates, mutual funds, ETFs, and money markets. While you may feel invincible as your mid-career is doing well, don't fall into the trap of overspending to keep up with the neighbors.
Always remain mentally prepared. The job market is tough. You could one day find yourself tapped to be laid off. Workers will likely face disruptions, like AI automating roles. After a couple of decades have passed, you might be thinking about a change. It's normal to think about a career pivot or reinvention to stay fresh and motivated. Be Honest With Yourself
At each interaction of your career journey, think about if you want to continue doing what you've been doing for so long. Consider thinking about new and different challenges. This is the mid-life career crisis, as you need to figure out what you want to be for the next phase of your work life.
It will seem daunting. When you're middle aged and after starting anew, it's not easy. Design a plan of bold action. Think of what you're good at, enjoy doing, have some talent for and the chance to earn a good living. Then, research what it takes to make that leap and do it. Don't procrastinate. Start today, as time quickly flies by. Reinventing or Pivoting
Reinventing your career can feel daunting, especially if you're accustomed to a high-paying profession, but lack passion for it. Fear of losing status or financial security often traps people in unfulfilling jobs. Start small and avoid rash decisions. Try embracing Japanese concepts like ikigai (finding purpose) and kaizen (continuous improvement) to guide your pivot. Seek roles aligning with your skills, interests, and acceptable pay to find fulfillment.
To move into a new career, create a fresh, compelling narrative. Highlight transferable skills that could make a hiring manager believe you can cross over to this new type of role. Refresh your résumé, LinkedIn profile and social media footprint to show how you have the skills and other attributes that make you a contender for this new adventure.
If you like your boss and company, you don't have to leave to make a pivot or reinvention. You can create your own role and reinvent yourself, while remaining at your firm. There is a trend called job crafting. This is the practice of reimagining and changing the nature of your role to fit your needs, wants, desires and ambition. The Third Stage
For some, in the late-career stage, typically after 25-30 years of work, the focus shifts to reinvention and winding down. Older workers may face ageism or industries disrupted by technology. There are many who believe that they have meaningful contributions to offer, and rather not retire too early. A 2024 AARP survey found that 57% of workers over 50 plan to work past the traditional retirement age, often in new roles or consulting.
Now that you're in the late 40s, 50s, or 60s, you still feel that you have a lot to offer. Rather than slowing down, now may be the time to take your career to the next level. It could lead to your last hurrah. It's now become very common for people to work in their seventies and eighties. After all these years, you may want to finally get that position in the C-suite.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Citi Maintains Neutral Rating on Simon Property Group (SPG)
Citi Maintains Neutral Rating on Simon Property Group (SPG)

Yahoo

time10 minutes ago

  • Yahoo

Citi Maintains Neutral Rating on Simon Property Group (SPG)

Simon Property Group, Inc. (NYSE:SPG) is one of the most undervalued stocks. On June 17, Citi trimmed its price target on SPG from $185 to $170 while reiterating a Neutral rating on the stock. The company adjusted its 2025 funds from operations (FFO) estimate downward to $12.21 from the previous $12.52, adding the impact of Q1 results that included one-time expenses and investment losses of $0.28 per share. Similarly, Citi revised its 2025 core FFO forecast to $12.49, a slight decrease from $12.52, mainly driven by more conservative projections for net operating income. A rooftop view of a bustling downtown area, emphasizing the company's investments in the real estate sector. The updated price target implies a valuation multiple of approximately 14x the expected 2025 core FFO, down from the earlier multiple of around 15x. Citi attributed this multiple compression to increased uncertainty regarding potential tariff impacts and the overall creditworthiness of tenants. This adjustment in price target stems from Simon's recent earnings performance and denotes a conservative outlook on the retail property market amid broader economic headwinds. Simon Property Group, Inc. (NYSE:SPG) is a self-managed and self-administered REIT specializing in the ownership, development, and operation of premier retail and mixed-use properties, including malls, outlets, and international destinations. While we acknowledge the potential of SPG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Sign in to access your portfolio

Truist Lifts COPT Defense Properties (CDP) PT to $30
Truist Lifts COPT Defense Properties (CDP) PT to $30

Yahoo

time10 minutes ago

  • Yahoo

Truist Lifts COPT Defense Properties (CDP) PT to $30

COPT Defense Properties (NYSE:CDP) is one of the most undervalued stocks. On June 10, Truist maintained a Hold rating on CDP and raised the price target from $29 to $30. With a robust 4.31% yield, the company has consistently paid dividends for the past 34 years, indicating its commitment to shareholder returns. The target price update reflects a refined valuation approach that involves discounted cash flow analysis along with forecasted net asset value. Analysts reported that COPT Defense Properties (NYSE:CDP) is advancing three developments set to launch in 2025, with more projects on deck for 2026 and 2027. The $308 million active portfolio is 62% pre-leased, with 30% of the costs already invested. Occupancy at COPT Defense is forecasted to dip slightly to 91.9% by the end of 2025, compared to 92.3% in the first quarter. The firm also projects a low single-digit positive increase in GAAP rental spreads. A security guard patrolling a defense facility, protecting critical technologies. Analysts indicate that COPT Defense Properties (NYSE:CDP) is unlikely to engage in any mergers, acquisitions, or property disposals in 2025. However, they are factoring in a $400 million unsecured note issuance for the fourth quarter. COPT Defense, a self-managed REIT, focuses on the ownership, operation, and development of mission-critical real estate assets located near or within major US Government defense installations. While we acknowledge the potential of CDP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

UnitedHealth Stock Is One of the Worst-Performing S&P 500 Stocks in 2025. Should You Buy the Dip?
UnitedHealth Stock Is One of the Worst-Performing S&P 500 Stocks in 2025. Should You Buy the Dip?

Yahoo

time10 minutes ago

  • Yahoo

UnitedHealth Stock Is One of the Worst-Performing S&P 500 Stocks in 2025. Should You Buy the Dip?

Wall Street is cheering fresh highs as the S&P 500 Index ($SPX) wraps a solid second quarter, closing June 2025 strong. The rally has been powered by cooling inflation, resilient earnings, and fading tariff concerns after April's policy shock. Just three months back, the market briefly dipped toward bear territory amid geopolitical tensions, China's AI push, tariff fears, and fiscal uncertainty, keeping investors on edge about the rebound's staying power. Despite the S&P rallying over 28% from its April lows of $4,835, the bull run has still left many big names behind. Nearly a third of the index's stocks still ended the first half of 2025 in the red. UnitedHealth (UNH), a giant in health insurance and managed care services, has plunged 39% so far in 2025. UNH stock has been hit by soaring Medicare Advantage costs, a probe into Medicare fraud, and a sudden CEO exit, making it the index's fourth-worst performer. Michael Saylor Says 'You'll Wish You'd Bought More' Bitcoin as MicroStrategy Doubles Down Is Microsoft Stock About to Go Nuclear? Is Super Micro Computer Stock a Buy, Sell, or Hold for July 2025? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! While UNH is at five-year lows, a 1.8% five-day bounce hints at some life. With the dividend-paying stock halved and trading at a compelling valuation, is this a classic 'buy the dip' setup? Or a moment for caution despite the allure of value and yield? Founded in 1977, UnitedHealth has grown into a $295 billion healthcare heavyweight. With its deep roots in health insurance and care services, the company runs on two powerhouse engines: UnitedHealthcare and Optum. UnitedHealthcare handles the insurance side, offering plans that serve over 50 million people. It's the backbone, giving the company scale, reach, and reliable revenue. But it's Optum that brings the spark, driving growth through data, tech, and pharmacy solutions. From analytics to care delivery, Optum's strategy pushes innovation across the system. Together, these segments give the company its edge in a complex healthcare landscape. UNH stock has been in free fall in 2025, hitting a low of $248.88 in May. Over the past 52 weeks, the stock has declined 38%, trailing far behind the broader S&P's surge of 13%. However, UNH stock is rebounding, up 1% over the past month. UnitedHealth's downfall in 2025 was not just a single bad headline. It was a chain reaction that started fast and spiraled hard. It kicked off on April 17, when the company shocked the Street by slashing its full-year earnings forecast. This was because a flood of higher-acuity Medicare Advantage patients drove costs far beyond expectations, exposing just how outdated and fragile their forecasting models had become. Then May hit like a wrecking ball. CEO Andrew Witty abruptly resigned, raising eyebrows amid growing pressure. Days later, reports surfaced of a U.S. Department of Justice investigation into alleged Medicare fraud. By mid-May, the stock had crashed, hitting five-year lows. Just when it seemed the damage was done, more scandal dropped with accusations of UnitedHealth secretly paying nursing homes to avoid costly hospital transfers. Even insider buying gave only a brief lift to UNH. In a short span, UnitedHealth went from a rock-solid name to a cautionary tale unraveling in real time. After its brutal springtime plunge, UNH stock is priced at 14 times forward earnings and 0.7 times sales, trading in bargain territory. Those multiples sit well below both the sector medians and its own five-year averages, catching the eye of value hunters sniffing out a possible rebound. Despite the stock's decline, UnitedHealth has signaled some confidence where it counts: dividends. In June, the company hiked its quarterly payout by 5.2% to $2.21, marking 15 consecutive years of increases. Paid out on June 24, the hike pushed its annual yield near 2.6%. On April 17, UnitedHealth reported Q1 2025 earnings, and it wasn't the kind of update Wall Street wanted to hear. Revenue climbed 9.8% year-over-year (YOY) to $109.6 billion but still came in shy of expectations. Adjusted EPS rose 4.2% to $7.20 yet missed the estimated mark of $7.27. UnitedHealthcare, the insurance arm, posted a solid 12.2% revenue gain to $84.6 billion. Meanwhile, Optum saw more modest growth of 4.6% to $63.9 billion, with Optum Rx doing the heavy lifting. Still, rising costs loomed large. Total operating expenses surged 9.4% annually to $100.5 billion. On the brighter side, the company exited the quarter with $34.3 billion in cash and short-term investments and generated $5.5 billion in operating cash flow. Shareholders weren't left in the cold either, with over $5 billion returned through buybacks and dividends. UnitedHealth's steep selloff wasn't just about Q1 results. It was the guidance cut that really rattled sentiment. Management slashed its 2025 adjusted EPS outlook to between $26 and $26.50, down from the initially forecast range of $29.50 to $30 in December 2024 and below fiscal 2024 adjusted EPS of $27.66. Surging Medicare Advantage costs and shifts in Optum's patient mix have taken a real bite. Now, all eyes are on the fiscal Q2 report, expected to be released on July 29 before the market opens. Analysts forecast the Q2 bottom line to be around $5.08 per share, down 25% YOY. Looking to fiscal 2025, adjusted EPS is expected to decline 20% annually to $22.07, then surge by 15% to $25.39 in fiscal 2026. Last Wednesday, UBS reiterated its 'Buy' rating on UNH stock but trimmed the price target to $385 from $400. The cut followed CEO Stephen Hemsley's cautious tone at the June 2 meeting, hinting at more conservative 2025 guidance. UBS anticipates fiscal 2025 EPS closer to $20, down from the earlier $22.50 consensus. Margins were also revised, with Medicare Advantage trimmed to 1.5% and Optum Health lowered to 4.5%. Despite the recent shakeups, Wall Street hasn't completely hit the panic button yet. Last month, UnitedHealth shook things up by axing broker commissions on select Medicare Advantage plans — a move aimed at trimming the cost that forced it to yank full-year guidance. Hightower Chief Investment Strategist Stephanie Link called it a smart pivot, saying the same issue 'got them in trouble' to begin with. Link is bracing for short-term volatility but stays bullish long-term, calling UNH stock 'too cheap' for a top-tier name in the industry. There's still optimism in the air, but with a touch of caution. UNH stock has a 'Moderate Buy' consensus overall, down from a consensus 'Strong Buy' rating a month ago. Of the 24 analysts covering the stock, 15 advise a 'Strong Buy,' two suggest a 'Moderate Buy,' and seven analysts play it safe with a 'Hold.' The mean price target of $363.43 implies shares could rise as much as 18%. The Street-high target of $440, way below this year's highs, signals that UNH has an upside potential of 43% from current levels. The U.S. healthcare industry, despite constant political firestorms, is built to endure. For years, UnitedHealth has stood as its crown jewel. Defensive, dividend-paying, and shock-resistant, it has been the kind of stock long-term investors can count on. But 2025 has shattered that illusion. While the broader market climbs to record highs, UnitedHealth's dramatic plunge reminds us that even giants can stumble hard. Sure, UNH stock now trades at a discount, offering an attractive dividend yield. Insiders are buying shares, and UnitedHealth still commands significant market share and robust cash flow. But is this really a 'buy the dip' moment? It's probably a bet that management can steady the ship, and the storm eventually clears. Until then, UnitedHealth sits in a gray zone between legacy and uncertainty, where long-term promise collides with short-term pain. Investors should exercise caution before jumping in. On the date of publication, Sristi Suman Jayaswal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store